Search - tctmd.com

Displaying 61 - 80 of 181

Sort: Relevancy | Date

News Conference News ESC 2017

Supplemental Oxygen Provides No Benefit to Patients With Suspected MI: DETO2X-AMI

Michael O'Riordan

August 28, 2017

News Conference News ESC 2017

Ultra-Low LDL Levels? FOURIER Suggests Efficacy of Evolocumab

Michael O'Riordan

August 28, 2017

News Conference News ESC 2017

ESC Updates Guidelines for Treating STEMI Patients

Michael O'Riordan

August 27, 2017

News Conference News ESC 2017

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

Michael O'Riordan

August 27, 2017

News Conference News ESC 2017

Mortality After Acute MI Halved Over Two Decades in Switzerland, With Greatest Gains by Women

Michael O'Riordan

August 26, 2017

News Daily News

Evolocumab Not Cost-Effective at Current List Price

Michael O'Riordan

August 23, 2017

News Daily News

TAVR in the US: Regional Variations in Numbers, Outcomes

Michael O'Riordan

August 22, 2017

News Daily News

PET More Accurate for Diagnosing CAD Than SPECT and CT Angiography: PACIFIC Study

Michael O'Riordan

August 17, 2017

News Daily News

FDA: Class I Recall for Cook’s Thoracic Endovascular Grafts

Michael O'Riordan

August 17, 2017

Studies Supporting Device Modifications Weak, Often Based on Surrogate Endpoints

News Daily News

FDA Clearance of Modified Devices Relies Heavily on Weak Studies, Surrogate Endpoints

Michael O'Riordan

August 16, 2017

News Daily News

Early Invasive Strategy Benefits Select High-Risk NSTE ACS Patients, Meta-analysis Suggests

Michael O'Riordan

August 14, 2017

News Daily News

Obese Cardiac Surgery Patients a Burden on ICU Resources

Michael O'Riordan

August 11, 2017

News Daily News

Reusing the Radial: Repeat Transradial Access Safe and Feasible, Even Within 24 Hours

Michael O'Riordan

August 09, 2017

News Daily News

Money-Back Guarantee for Evolocumab Has Little Impact on Cost-Effectiveness

Michael O'Riordan

August 08, 2017

News Daily News

CKD Patients Undergoing PCI Much Less Likely to Receive Potent P2Y12 Inhibition

Michael O'Riordan

August 04, 2017

News Daily News

Many Stroke Patients Stop Statins or Never Start, With Dire Consequences

Michael O'Riordan

August 02, 2017

News Daily News

‘Remnant’ Cholesterol Linked With CVD Risk, Even When LDL Levels Are Low

Michael O'Riordan

August 01, 2017

News Daily News

Boston Scientific Scraps Biodegradable Scaffold Program

Michael O'Riordan

August 01, 2017

News Daily News

E-Cigarettes Aid in Smoking Cessation, US Study Suggests

Michael O'Riordan

July 27, 2017

News Daily News

Staying on Statins After an Adverse Event Lowers Risks of Death, MI or Stroke

Michael O'Riordan

July 25, 2017

Advertisement

Supplemental Oxygen Provides No Benefit to Patients With Suspected MI: DETO2X-AMI

Ultra-Low LDL Levels? FOURIER Suggests Efficacy of Evolocumab

ESC Updates Guidelines for Treating STEMI Patients

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

Mortality After Acute MI Halved Over Two Decades in Switzerland, With Greatest Gains by Women

Evolocumab Not Cost-Effective at Current List Price

TAVR in the US: Regional Variations in Numbers, Outcomes

PET More Accurate for Diagnosing CAD Than SPECT and CT Angiography: PACIFIC Study

FDA: Class I Recall for Cook’s Thoracic Endovascular Grafts

FDA Clearance of Modified Devices Relies Heavily on Weak Studies, Surrogate Endpoints

Early Invasive Strategy Benefits Select High-Risk NSTE ACS Patients, Meta-analysis Suggests

Obese Cardiac Surgery Patients a Burden on ICU Resources

Reusing the Radial: Repeat Transradial Access Safe and Feasible, Even Within 24 Hours

Money-Back Guarantee for Evolocumab Has Little Impact on Cost-Effectiveness

CKD Patients Undergoing PCI Much Less Likely to Receive Potent P2Y12 Inhibition

Many Stroke Patients Stop Statins or Never Start, With Dire Consequences

‘Remnant’ Cholesterol Linked With CVD Risk, Even When LDL Levels Are Low

Boston Scientific Scraps Biodegradable Scaffold Program

E-Cigarettes Aid in Smoking Cessation, US Study Suggests

Staying on Statins After an Adverse Event Lowers Risks of Death, MI or Stroke

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content